Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiotoxicity in the workplace.

N L Benowitz1

  • 1Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco.

Occupational Medicine (Philadelphia, Pa.)
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender differences in the pharmacology of nicotine addiction.

Addiction biology·2016
Same author

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Clinical pharmacology and therapeutics·2014
Same author

Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.

Clinical pharmacology and therapeutics·2013
Same author

CYP2A6 genotype but not age determines cotinine half-life in infants and children.

Clinical pharmacology and therapeutics·2013
Same author

CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.

Clinical pharmacology and therapeutics·2012
Same journal

Mental health issues: ethical considerations.

Occupational medicine (Philadelphia, Pa.)·2002
Same journal

Ethics in the locker room: the challenges for team physicians.

Occupational medicine (Philadelphia, Pa.)·2002
Same journal

Ethical issues in worker productivity.

Occupational medicine (Philadelphia, Pa.)·2002
Same journal

Protecting posterity: the occupational physician's ethical and legal obligations to pregnant workers.

Occupational medicine (Philadelphia, Pa.)·2002
Same journal

Genetic testing: ethical implications in the workplace.

Occupational medicine (Philadelphia, Pa.)·2002
Same journal

Ethical issues in occupational disease outbreak investigations.

Occupational medicine (Philadelphia, Pa.)·2002
See all related articles

This review explores toxic cardiovascular disease caused by specific chemical exposures. It details the epidemiology, mechanisms, and clinical features of various toxins, aiding in understanding their cardiovascular impact.

Area of Science:

  • Environmental Health
  • Toxicology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) can arise from chemical exposures, but establishing direct causality in individual cases is challenging.
  • Numerous chemicals are suspected contributors to toxic cardiovascular disease.
  • Understanding these links is crucial for public health and clinical practice.

Purpose of the Study:

  • To review toxic cardiovascular disease stemming from specific chemical exposures.
  • To elucidate the types of injury, epidemiology, mechanisms of toxicity, and clinical features associated with these toxins.
  • To provide a comprehensive overview for clinicians and researchers.

Main Methods:

  • Literature review of toxic cardiovascular disease.
  • Analysis of specific toxins including carbon disulfide, carbon monoxide, organic nitrates, halogenated hydrocarbons, lead, cobalt, arsenic/arsine, cadmium, and antimony.

Related Experiment Videos

  • Focus on injury types, epidemiology, mechanisms, and clinical presentation.

    • Main Results:

    • Detailed discussion of cardiovascular injury from specific toxins.
    • Epidemiological data, toxicological mechanisms, and clinical manifestations are presented for each chemical.
    • Highlights the difficulty in establishing individual causality for toxic exposures.

    Conclusions:

    • Specific chemical exposures are significant contributors to cardiovascular disease.
    • Recognizing the patterns of injury, epidemiology, and clinical features aids in diagnosis and prevention.
    • Further research is needed to solidify causality in individual patient cases.